Migration of dendritic cell subsets and their precursors

Annual Review of Immunology

Volumn 26, Issue , 2008, Pages 293-316

  Randolph, Gwendalyn J ^a   Ochando, Jordi ^b   Partida Sánchez, Santiago ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chemotaxis; Lymph node; Lymphatic vessel; Postcapillary venule

Indexed keywords

CD8ALPHA ANTIGEN; CELL RECEPTOR; CELL SURFACE PROTEIN; CHEMOKINE RECEPTOR CCR7; MONOCYTE CHEMOTACTIC PROTEIN;

BONE MARROW CELL; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CHEMOTAXIS; CIRCULATION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; LANGERHANS CELL; LYMPH NODE; LYMPH VESSEL; LYMPHOID ORGAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN CELL; STEM CELL; THYMOCYTE; TISSUE INJURY; VENULE;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS; DENDRITIC CELLS; HUMANS; LYMPH; LYMPHOID TISSUE; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 42649091089     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.26.021607.090254     Document Type: Review

References (148)

1. Trombetta ES, Mellman I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975-1028
2. Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ. 2006. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 176:3578-84
3. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-71
4. Randolph GJ, Angeli V, Swartz MA. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5:617-28
5. Gretz JE, Anderson AO, Shaw S. 1997. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156:11-24
6. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, et al. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22:19-29
7. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
8. Mebius RE, Kraal G. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5:606-16
9. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8:578-83
10. Shortman K, Naik SH. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:19-30
11. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, et al. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819-29
12. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-60
13. Ato M, Stager S, Engwerda CR, Kaye PM. 2002. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat. Immunol. 3:1185-91
14. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100:1734-41
15. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, et al. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-80
16. Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, et al. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7:663-71
17. Pugh CW, MacPherson GG, Steer HW. 1983. Characterization of nonlymphoid cells derived from rat peripheral lymph. J. Exp. Med. 157:1758-79
18. MacPherson GG, Jenkins CD, Stein MJ, Edwards C. 1995. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF dependence. J. Immunol. 154:1317-22
19. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Müller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
20. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12
21. Vrlladangos JA, Heath WR. 2005. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin. Immunol. 17:262-72
22. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, et al. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:1135-41
23. Macatonia SE, Edwards AJ, Knight SC. 1986. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 59:509-14
24. Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant C, Vincent C, et al. 1999. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29:2695-704
25. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643-54
26. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-20
27. + dendritic cells but not by Langerhans cells. Science 301:1925-28
28. Kimber I, Cumberbatch M. 1992. Stimulation of Langerhans cell migration by tumor necrosis factor α (TNF-α). J. Invest. Dermatol. 99:48S-50S
29. Cumberbatch M, Griffiths CE, Tucker SC, Dearman RJ, Kimber I. 1999. Tumour necrosis factor-α induces Langerhans cell migration in humans. Br. J. Dermatol. 141:192-200
30. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. 2000. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757-68
31. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, et al. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-23
32. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M. 2005. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J. Exp. Med. 202:687-96
33. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-73
34. Leon B, Lopez-Bravo M, Ardavin C. 2007. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26:519-31
35. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, et al. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101:8670-75
36. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, et al. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153-62
37. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, et al. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8(+) T cell crosspriming in vivo. Immunity 24:191-201
38. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J. Exp. Med. 189:593-98
39. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-61
40. Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM. 2006. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177:1618-27
41. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, et al. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-46
42. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-61
43. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. 2003. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171:6466-77
44. Blasius A, Vermi W, Krug A, Facchetti F, Cella M, Colonna M. 2004. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-α. Blood 103:4201-6
45. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, et al. 2006. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107:3600-8
46. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171-78
47. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, et al. 2005. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201:509-15
48. Zabel BA, Silverio AM, Butcher EC. 2005. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 174:244-51
49. Masten BJ, Olson GK, Tarleton CA, Rund C, Schuyler M, et al. 2006. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol. 177:7784-93
50. Imhof BA, Aurrand-Lions M. 2004. Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4:432-44
51. Woltman AM, de Fijter JW, Zuidwijk K, Vlug AG, Bajema IM, et al. 2007. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int. 71:1001-8
52. Jahnsen FL, Gran E, Haye R, Brandtzaeg P. 2004. Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes. Am. J. Respir. Cell Mol. Biol. 30:31-37
53. De Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, et al. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200:89-98
54. Wendland M, Czeloth N, Mach N, Malissen B, Kremmer E, et al. 2007. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. USA 104:6347-52
55. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. 2001. Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:237-43
56. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7:652-62
57. Yrlid U, Jenkins CD, MacPherson GG. 2006. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady state conditions. J. Immunol. 176:4155-62
58. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70:4501-9
59. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-8
60. Cavanagh LL, Bonasio R, Mazo IB, Halin C, Cheng G, et al. 2005. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat. Immunol. 6:1029-37
61. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, et al. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203-15
62. Rennert PD, Hochman PS, Flavell RA, Chaplin DD, Jayaraman S, et al. 2001. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice. J. Exp. Med. 193:1227-38
63. Enioutina EY, Bareyan D, Daynes RA. 2007. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 25:1236-49
64. Liu YJ. 2006. A unified theory of central tolerance in the thymus. Trends Immunol. 27:215-21
65. Mathis D, Benoist C. 2004. Back to central tolerance. Immunity 20:509-16
66. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. 2006. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7:1092-100
67. Larsen CP, Morris PJ, Austyn JM. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171:307-14
68. Saiki T, Ezaki T, Ogawa M, Matsuno K. 2001. Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic-nodes. Transplantation 71:1806-15
69. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101:11779-84
70. Ochando J, Krieger NR, Bromberg JS. 2006. Direct vs. indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am. J. Transplant. 6:2488-96
71. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. 2001. Mice lacking expression of the chemokines ccl21-ser and ccl19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193:207-18
72. Glass CK, Witztum JL. 2001. Atherosclerosis: the road ahead. Cell 104:503-16
73. Gerrity RG. 1981. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol. 103:191-200
74. Huang Y, Rumschitzki D, Chien S, Weinbaum S. 1994. A fiber matrix model for the growth of macromolecular leakage spots in the arterial intima. J. Biomech. Eng. 116:430-45
75. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW. 2001. IFN-γ action in the media of the great elastic arteries, a novel immunoprivileged site. J. Clin. Invest. 107:R15-22
76. Deleted in proof
77. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101:11779-84
78. Van Haastert PJ, Devreotes PN. 2004. Chemotaxis: signalling the way forward. Nat. Rev. Mol. Cell Biol. 5:626-34
79. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. 2006. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176:5153-9
80. Bourne HR. 1997. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:134-42
81. Kuang Y, Wu Y, Jiang H, Wu D. 1996. Selective G protein coupling by C-C chemokine receptors. J. Biol. Chem. 271:3975-78
82. Wu D. 2005. Signaling mechanisms for regulation of chemotaxis. Cell Res. 15:52-56
83. Del Prete A, Vermi W, Dander E, Otero K, Barberis L, et al. 2004. Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ-deficient mice. EMBO J. 23:3505-15
84. Shin EH, Lee HY, Bae YS. 2006. Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis. Biochem. Biophys. Res. Commun. 348:606-11
85. Andrew N, Insall RH. 2007. Chemotaxis in shallow gradients is mediated independently of PtdIns 3-kinase by biased choices between random protrusions. Nat. Cell Biol. 9:193-200
86. Smith DF, Deem TL, Bruce AC, Reutershan J, Wu D, Ley K. 2006. Leukocyte phosphoinositide-3 kinase γ is required for chemokine-induced, sustained adhesion under flow in vivo. J. Leukoc. Biol. 80:1491-99
87. Riol-Blanco L, Sanchez-Sanchez N, Torres A, Tejedor A, Narumiya S, et al. 2005. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 174:4070-80
88. Sanchez-Sanchez N, Riol-Blanco L, de la Rosa G, Puig-Kroger A, Garcia-Bordas J, et al. 2004. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104:619-25
89. Iijima N, Yanagawa Y, Clingan JM, Onoe K. 2005. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells. Int. Immunol. 17:1201-12
90. Scandella E, Men Y, Legler DF, Gillessen S, Prikler L, et al. 2004. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103:1595-601
91. Luft T, Maraskovsky E, Schnurr M, Knebel K, Kirsch M, et al. 2004. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104:1066-74
92. Galgani M, De Rosa V, De Simone S, Leonardi A, D'Oro U, et al. 2004. Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling. J. Biol. Chem. 279:32507-14
93. Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, et al. 2001. Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages. Int. Immunol. 13:167-79
94. Kitanaka N, Owada Y, Okuyama R, Sakagami H, Nourani MR, et al. 2006. Epidermal-type fatty acid binding protein as a negative regulator of IL-12 production in dendritic cells. Biochem. Biophys. Res. Commun. 345:459-66
95. Nagayama H, Sato K, Kawasaki H, Enomoto M, Morimoto C, et al. 2000. IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J. Immunol. 165:59-66
96. Khader SA, Partida-Sánchez S, Bell G, Jelley-Gibbs DM, Swain S, et al. 2006. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203:1805-15
97. Yanagawa Y, Onoe K. 2006. Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor κB-inducing kinase in mature dendritic cells. Immunology 117:526-35
98. Wang S, Hong S, Yang J, Qian J, Zhang X, et al. 2006. Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood 108:4071-77
99. Nakagawa S, Ohtani T, Mizuashi M, Mollah ZU, Ito Y, et al. 2004. p38 mitogen-activated protein kinase mediates dual role of UVB radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J. Invest. Dermatol. 123:361-70
100. Aiba S, Manome H, Nakagawa S, Mollah ZU, Mizuashi M, et al. 2003. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 120:390-99
101. Shi GX, Harrison K, Han SB, Moratz C, Kehrl JH. 2004. Toll-like receptor signaling-alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J. Immunol. 172:5175-84
102. Oppermann M. 2004. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell. Signal. 16:1201-10
103. q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J. Exp. Med. 204:2705-18
104. Klinker JE, Wenzel-Seifert K, Seifert R. 1996. G-protein-coupled receptors in HL-60 human leukemia cells. Gen. Pharmacol. 27:33-54
105. Riobo NA, Manning DR. 2005. Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol. Sci. 26:146-54
106. Schaerli P, Moser B. 2005. Chemokines: control of primary and memory T-cell traffic. Immunol. Res. 31:57-74
107. Weninger W, von Andrian UH. 2003. Chemokine regulation of naive T cell traffic in health and disease. Semin. Immunol. 15:257-70
108. Muller G, Hopken UE, Lipp M. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195:117-35
109. Muller G, Lipp M. 2003. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 10:325-34
110. Sozzani S. 2005. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 16:581-92
111. Kim CH. 2005. The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr. Opin. Hematol. 12:298-304
112. Steinman RM, Hemmi H. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58
113. Crow MK. 2006. Modification of accessory molecule signaling. Springer Semin. Immunopathol. 27:409-24
114. Hemmi H, Akira S. 2005. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86:120-35
115. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16:257-70
116. Lindner I, Cejas PJ, Carlson LM, Torruellas J, Plano GV, Lee KP. 2007. Signal transduction in DC differentiation: winged messengers and Achilles' heel. Adv. Exp. Med. Biol. 590:1-29
117. Colonna M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3:445-53
118. Bouchon A, Hernandez-Munain C, Cella M, Colonna M. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111-22
119. Lanier LL, Bakker AB. 2000. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 21:611-14
120. Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, et al. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345-53
121. Tessarz AS, Weiler S, Zanzinger K, Angelisova P, Horejsi V, Cerwenka A. 2007. Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J. Immunol. 178:1991-99
122. Bagley KC, Abdelwahab SF, Tuskan RG, Lewis GK. 2004. Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists. Clin. Diagn. Lab. Immunol. 11:77-82
123. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, et al. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4:485-90
124. Yang D, Chen Q, Gertz B, He R, Phulsuksombati M, et al. 2002. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukoc. Biol. 72:598-607
125. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, et al. 2002. Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100:925-32
126. Partida-Sánchez S, Rivero-Nava L, Shi G, Lund FE. 2007. CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses. Adv. Exp. Med. Biol. 590:171-83
127. Lund FE. 2006. Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol. Med. 12:328-33
128. Partida-Sánchez S, Goodrich S, Kusser K, Oppenheimer N, Randall TD, Lund FE. 2004. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20:279-91
129. Partida-Sánchez S, Randall TD, Lund FE. 2003. Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity. Microbes Infect. 5:49-58
130. Partida-Sanchez S, Gasser A, Fliegert R, Siebrands CC, Dammermann W, et al. 2007. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by ADP-ribose, the major product generated by the CD38 enzyme reaction. J. Immunol. 179:7827-39
131. Fliegert R, Gasser A, Guse AH. 2007. Regulation of calcium signalling by adenine-based second messengers. Biochem. Soc. Trans. 35:109-14
132. 2+ permeable cation channels: from gene to biological function. Cell Calcium 33:519-31
133. Massullo P, Sumoza-Toledo A, Bhagat H, Partida-Sanchez S. 2006. TRPM channels, calcium and redox sensors during innate immune responses. Semin. Cell Dev. Biol. 17:654-66
134. Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE, McNulty S. 2006. Tissue distribution profiles of the human TRPM cation channel family. J. Recept. Signal. Transduct. Res. 26:159-78
135. Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E. 2004. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int. Immunol. 16:799-809
136. Iqbal J, Zaidi M. 2007. CD38 is required for priming by TNF-α: a mechanism for extracellular coordination of cell fate. Am. J. Physiol. Renal Physiol. 292:F1283-90
137. Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, et al. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 34:320-29
138. Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, et al. 2003. Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J. Exp. Med. 198:1253-63
139. Watts C, Zaru R, Prescott AR, Wallin RP, West MA. 2007. Proximal effects of Toll-like receptor activation in dendritic cells. Curr. Opin. Immunol. 19:73-78
140. Pasare C, Medzhitov R. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560:11-18
141. Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11:653-60
142. Angeli V, Staumont D, Charbonnier AS, Hammad H, Gosset P, et al. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172:3822-29
143. Hartiala P, Hytonen J, Pelkonen J, Kimppa K, West A, et al. 2007. Transcriptional response of human dendritic cells to Borrelia garinii-defective CD38 and CCR7 expression detected. J. Leukoc. Biol. 82:33-43
144. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P. 2007. The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leukoc. Biol. 81:84-91
145. la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G. 2003. Alerting and tuning the immune response by extracellular nucleotides. J. Leukoc. Biol. 73:339-43
146. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, et al. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600
147. la Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Idzko M, et al. 2002. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99:1715-22
148. Bray M, Geisbert TW. 2005. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int. J. Biochem. Cell Biol. 37:1560-66